Jupai (JP) & R1 RCM (RCM) Financial Survey

Jupai (NYSE:JP) and R1 RCM (NASDAQ:RCM) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Risk & Volatility

Jupai has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, R1 RCM has a beta of -0.76, suggesting that its share price is 176% less volatile than the S&P 500.

Institutional & Insider Ownership

11.2% of Jupai shares are held by institutional investors. Comparatively, 49.8% of R1 RCM shares are held by institutional investors. 59.4% of R1 RCM shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


Jupai pays an annual dividend of $0.58 per share and has a dividend yield of 8.0%. R1 RCM does not pay a dividend.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Jupai and R1 RCM, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jupai 0 0 0 0 N/A
R1 RCM 0 1 3 0 2.75

R1 RCM has a consensus target price of $11.75, indicating a potential upside of 39.22%. Given R1 RCM’s higher probable upside, analysts plainly believe R1 RCM is more favorable than Jupai.


This table compares Jupai and R1 RCM’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Jupai 23.07% 23.85% 17.18%
R1 RCM -11.31% -52.71% -4.63%

Earnings & Valuation

This table compares Jupai and R1 RCM’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Jupai $262.23 million 0.90 $62.93 million N/A N/A
R1 RCM $449.80 million 2.06 -$58.80 million ($0.44) -19.18

Jupai has higher earnings, but lower revenue than R1 RCM.


Jupai beats R1 RCM on 7 of the 13 factors compared between the two stocks.

About Jupai

Jupai Holdings Limited, together with its subsidiaries, provides wealth management products and advisory services to high-net-worth individuals in China. It also provides asset management services, including management of real estate or related funds and other fund products. The company offers services for fixed income products, private equity and venture capital funds, and public market products, as well as other products, including overseas insurance products and foreign-currency denominated alternative investments. In addition, it provides fund management services, as well as advisory and administrative services. The company was formerly known as Jupai Investment Group and changed its name to Jupai Holdings Limited in December 2014. Jupai Holdings Limited was founded in 2010 and is headquartered in Shanghai, China.

About R1 RCM

R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides modular services comprising physician advisory services, which assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; and revenue capture services, including charge capture, charge description master maintenance, and pricing services. It serves single or multi-hospital healthcare systems, and their respective affiliated ambulatory clinics and physician practice groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is headquartered in Chicago, Illinois.

Receive News & Ratings for Jupai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jupai and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply